Hypophosphatemia

Known as: Hypophosphataemia, Hypophosphatemia [Disease/Finding], Low blood phosphate level 
A condition of an abnormally low level of PHOSPHATES in the blood.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Fibroblast growth factor (FGF) 23 inhibits renal phosphate reabsorption by activating FGF receptor (FGFR) 1c in a Klotho… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BACKGROUND The optimal intensity of continuous renal-replacement therapy remains unclear. We conducted a multicenter, randomized… (More)
  • figure 1
  • table 1
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
BACKGROUND No effective systemic therapy exists for patients with advanced hepatocellular carcinoma. A preliminary study… (More)
  • figure 1
  • table 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Hypophosphatemia is a genetically heterogeneous disease. Here, we mapped an autosomal recessive form (designated ARHP) to… (More)
  • figure 1
  • table 1
Is this relevant?
Review
2006
Review
2006
Optimal cellular function is dependent on maintenance of a normal serum phosphorus concentration. Serum phosphorus concentration… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Fibroblast growth factor-23 (FGF-23), a recently identified molecule that is mutated in patients with autosomal dominant… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND Mutations in fibroblast growth factor 23 (FGF-23) cause autosomal dominant hypophosphatemic rickets. Clinical and… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
FGF-23 is involved in the pathogenesis of two similar hypophosphatemic diseases, autosomal dominant hypophosphatemic rickets… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Tumor-induced osteomalacia (TIO) is one of the paraneoplastic diseases characterized by hypophosphatemia caused by renal… (More)
  • figure 2
  • table 1
  • figure 1
  • figure 4
  • table 2
Is this relevant?
Highly Cited
1976
Highly Cited
1976
A new dominant mutation in the laboratory mouse, hypophosphatemia (gene symbol Hyp), has been identified. The Hyp gene is located… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?